These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25678602)

  • 1. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice.
    Boriani G; Lane DA; Windecker S; Huber K; Kirchhof P; Lip GY
    Europace; 2015 Sep; 17(9):1319-22. PubMed ID: 25678602
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
    Lip GY; Windecker S; Huber K; Kirchhof P; Marin F; Ten Berg JM; Haeusler KG; Boriani G; Capodanno D; Gilard M; Zeymer U; Lane D; ; Storey RF; Bueno H; Collet JP; Fauchier L; Halvorsen S; Lettino M; Morais J; Mueller C; Potpara TS; Rasmussen LH; Rubboli A; Tamargo J; Valgimigli M; Zamorano JL
    Eur Heart J; 2014 Dec; 35(45):3155-79. PubMed ID: 25154388
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention.
    Ruiz-Nodar JM; Marín F; Lip GY
    Rev Esp Cardiol (Engl Ed); 2013 Jan; 66(1):12-6. PubMed ID: 23098580
    [No Abstract]   [Full Text] [Related]  

  • 4. What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?
    Tseng AS; Shamoun FE; Marks LA; Agrwal N
    Cleve Clin J Med; 2021 Jul; 88(7):389-392. PubMed ID: 34210713
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic therapy for patients with chronic coronary syndromes.
    Parker WA; Storey RF
    Heart; 2021 Jun; 107(11):925-933. PubMed ID: 33127651
    [No Abstract]   [Full Text] [Related]  

  • 6. Optimizing Management of Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: The Importance of Distinguishing Pre-Existing From New Onset Atrial Fibrillation.
    Kalra A; Reardon MJ; Kleiman NS
    JACC Cardiovasc Interv; 2017 Jan; 10(1):101-103. PubMed ID: 28057276
    [No Abstract]   [Full Text] [Related]  

  • 7. The Waxing and Waning of Antithrombotic Therapy in Cardiovascular Disease - Where Is the Moon Now?
    Effron MB; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):457-459. PubMed ID: 29366879
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic therapy in anticoagulated patients with atrial fibrillation presenting with acute coronary syndromes and/or undergoing percutaneous coronary intervention/stenting.
    Wrigley BJ; Tapp LD; Shantsila E; Lip GY
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):290-3. PubMed ID: 20693960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute coronary syndrome in patients with non-valvular atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Dagres N; Estner HL; Larsen TB; Blomström-Lundqvist C;
    Europace; 2014 Feb; 16(2):293-8. PubMed ID: 24478291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis.
    Osman M; Kheiri B; Munir MB; Moreland JA; Balla S; Kapadia S
    J Thromb Thrombolysis; 2019 Oct; 48(3):516-518. PubMed ID: 31175529
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
    Capodanno D; Angiolillo DJ
    Circ Cardiovasc Interv; 2014 Feb; 7(1):113-24. PubMed ID: 24550531
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombotic treatment in patients with acute coronary syndromes and atrial fibrillation. What is established and what is missing.
    Tsioufis C
    Hellenic J Cardiol; 2018; 59(1):66-67. PubMed ID: 29704565
    [No Abstract]   [Full Text] [Related]  

  • 13. Triple Antithrombotic Therapy in Atrial Fibrillation Patients With an Indication for Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A Case-Based Review of the Current Evidence.
    Picard F; Tadros VX; Asgar AW
    Circ Cardiovasc Interv; 2015 Dec; 8(12):e003217. PubMed ID: 26643741
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Perspectives in cardiology: evidence of efficacy in atrial fibrillation and hopes in acute coronary syndrome].
    Le Heuzey JY; Marijon E; Otmani A; Lepillier A; Waintraub X; Lavergne T; Pornin M
    Ann Fr Anesth Reanim; 2009 Sep; 28(9 Suppl):S34-8. PubMed ID: 19875004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role.
    Alexopoulos D; Vlachakis P; Lekakis J
    Cardiovasc Drugs Ther; 2017 Jun; 31(3):319-324. PubMed ID: 28643219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial.
    Fudim M; Wojdyla DM; Alexander JH; Goodman SG; Mehran R; Windecker S; Aronson R; Vinereanu D; Halvorsen S; Bahit MC; Granger CB; Lopes RD
    J Am Heart Assoc; 2021 Dec; 10(24):e023143. PubMed ID: 34873913
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Lopes RD; Hong H; Alexander JH
    Eur Heart J; 2019 Dec; 40(46):3768-3770. PubMed ID: 31774111
    [No Abstract]   [Full Text] [Related]  

  • 20. Trifecta or triple threat? The challenge of post-PCI management in patients receiving chronic oral anticoagulant therapy.
    Healey JS
    Can J Cardiol; 2013 Feb; 29(2):136-8. PubMed ID: 23089529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.